Live tape
Top 8, mentions 7d9,263GOOGL1,849 mentions▲ +0.04SNDK1,521 mentions▲ +0.11NVDA1,123 mentions▲ +0.08META1,106 mentions▲ +0.03SPCX1,077 mentions▲ +0.09NBIS965 mentions▲ +0.09HTZ837 mentions▲ +0.09VOO785 mentions▲ +0.09

Equity · Healthcare

BLTE

Belite Bio, Inc · NasdaqCM

$162.66 −0.44% 1D Finazon · prior-day close · Aug 18, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$180 $120 21 May 18 Aug

The line runs $144 on 21 May through $162.66 on 18 August, on a scale from $120 to $180. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BLTE over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $144 on 21 May 2026 through $162.66 on 18 August 2026.

52-week range $62 – $191
Avg volume 32.6K

Finazon · prior-day close · as of Aug 19, 2026

Filings 3 sets

BLTE reported financials

SEC EDGAR XBRL

BLTE reported net income of −$77.6M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$77.6M 31 Dec 2025 fiscal year
Diluted EPS −$2.31 31 Dec 2025 fiscal year
Total assets $780.6M 31 Dec 2025 at period end
Total equity $770.5M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

BLTE institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a BLTE position for the quarter ended 30 Jun 2026 — a combined $204.5M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −13.2% shares 494,564 $76.2M
Maverick Capital New position 396,311 $61.0M
Citadel Advisors Added +9,171.3% shares 186,168 $28.7M
Duquesne Family Office Held (±25%) 106,100 $16.3M
Renaissance Technologies Held (±25%) +7.2% shares 55,763 $8.6M
Point72 Asset Management New position 51,186 $7.9M
Two Sigma Investments New position 38,100 $5.9M
Tudor Investment Corp Exited

Source: SEC EDGAR 13F filings

BLTE fails-to-deliver

SEC CNS data

On 31 Jul 2026, 27 shares of BLTE failed to deliver (about $4K).

Settlement date Shares failed Notional % of shares out
31 Jul 2026 27 $4K <0.001%
29 Jul 2026 48 $7K <0.001%
27 Jul 2026 1,303 $200K 0.003%
20 Jul 2026 82 $12K <0.001%
17 Jul 2026 47 $7K <0.001%

Source: SEC fails-to-deliver (CNS) data